HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Patent Expiries to Boost US Generics Market

US generics market is forecasted to surge at a CAGR of around 10% during 2009-2012, driven by patent expiries of key blockbusters drugs in the market, says RNCOS.

 



(EMAILWIRE.COM, August 27, 2009 ) New Delhi, India - After being affected by global recession, US government is now aiming to reduce healthcare cost by increasing access to generics drugs. This has encouraged the generics manufacturers in different countries to enter the field. Boosted by patent expiry of several blockbusters drugs having billions of sales per year, market is expected to grow faster than before. This has been resulting into a healthcare reform in the country. The US generics market is anticipated to grow at a CAGR of around 10% during 2009-2012. This projected growth rate makes the market attractive for new investments, says our new analytical study “Booming US Generic Drug Market”.

The report studies the current trends as well as developments taking place in the US generics market. We have found that generic drugs hold a smaller share in the US pharma market as compared to the branded drugs, but it is surging at more than double the pace of the branded drugs market. Various factors like favorable political environment, patent expiries of key blockbusters, and low costs of generics have strongly supported the growth rate. On account of these factors generics market in the US is expected to register a double digit growth rate, says an analyst at RNCOS.

We have noted that during 2008-2012, patents of blockbusters having value of more than US$ 60 Billion are going to expire. This expiration will further lead the biogenerics market to register good growth in near future.

The report analyzes key markets and segments of the US generic drugs market to give an account on the market’s future scenario. Our industry experts say that government should take cautious approach in company deals that are aimed at preventing generics from getting launched in the market after patent expiration. The report highlights the factors propelling the growth of the US generics market. Apart from this, the report provides rational analysis on the concerned market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM589.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012